Human leukocyte antigen (HLA)-G during pregnancy part I: Correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term

Human Immunology

Volumn 76, Issue 4, 2015, Pages 254-259

  Klitkou, Louise ^a   Dahl, Mette ^b   Hviid, Thomas Vauvert F ^b   Djurisic, Snezana ^b   Piosik, Zofia Maria ^a   Skovbo, Peter ^a   Møller, Anna Margrethe ^a   Steffensen, Rudi ^a   Christiansen, Ole B ^a,c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

HLA G; MHC; Pregnancy; SHLA G; Umbilical cord blood

Indexed keywords

HLA G ANTIGEN;

ADULT; ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS WEIGHT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD; BLOOD; FETUS BLOOD; FOLLOW UP; GESTATIONAL AGE; IMMUNOLOGY; METABOLISM; PASSIVE IMMUNIZATION; PLACENTA CIRCULATION; SECOND TRIMESTER PREGNANCY;

COHORT STUDIES; FEMALE; FETAL BLOOD; FOLLOW-UP STUDIES; GESTATIONAL AGE; HLA-G ANTIGENS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; PLACENTAL CIRCULATION; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 84933181028     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.01.013     Document Type: Article

References (43)

1. Ellis S.A., Palmer M.S., McMichael A.J. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol 1990, 144:731-735.
2. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
3. Redman C.W., McMichael A.J., Stirrat G.M., Sunderland C.A., Ting A. Class 1 major histocompatibility complex antigens on human extra-villous trophoblast. Immunology 1984, 52:457-468.
4. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997, 186:1809.
5. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998, 160:3096-3100.
6. Rajagopalan S., Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999, 189:1093-1100.
7. Rizzo R., Vercammen M., van de Velde H., Horn P.A., Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci 2011, 68:341-352.
8. Gonzalez A., Rebmann V., LeMaoult J., Horn P.A., Carosella E.D., Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci 2012, 49:63-84.
9. Ishitani A., Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992, 89:3947-3951.
10. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000, 61:1138-1149.
11. Solier C., Aguerre-Girr M., Lenfant F., Campan A., Berrebi A., Rebmann V., et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002, 32:3576-3586.
12. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003, 171:1376-1384.
13. Morales P.J., Pace J.L., Platt J.S., Langat D.K., Hunt J.S. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007, 122:179-188.
14. Hunt J.S., Jadhav L., Chu W., Geraghty D.E., Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000, 183:682-688.
15. Fuzzi B., Rizzo R., Criscuoli L., Noci I., Melchiorri L., Scarselli B., et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002, 32:311-315.
16. Rizzo R., Fuzzi B., Stignani M., Criscuoli L., Melchiorri L., Dabizzi S., et al. Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF?. J Reprod Immunol 2007, 74:133-142.
17. Langat D.K., Sue Platt J., Tawfik O., Fazleabas A.T., Hunt J.S. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. J Reprod Immunol 2006, 71:75-86.
18. Larsen M.H., Bzorek M., Pass M.B., Larsen L.G., Nielsen M.W., Svendsen S.G., et al. Human leukocyte antigen-G in the male reproductive system and in seminal plasma. Mol Hum Reprod 2011, 17:727-738.
19. Rebmann V., Pfeiffer K., Passler M., Ferrone S., Maier S., Weiss E., et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999, 53:14-22.
20. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., Baricordi O.R. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56:135-141.
21. Plaks V., Rinkenberger J., Dai J., Flannery M., Sund M., Kanasaki K., et al. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci USA 2013, 110:11109-11114.
22. Dahl M., Hviid T.V. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum Reprod Update 2012, 18:92-109.
23. Hviid T.V. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 2006, 12:209-232.
24. Harrison G.A., Humphrey K.E., Jakobsen I.B., Cooper D.W. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993, 2:2200.
25. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72:335-341.
26. Rizzo R., Hviid T.V., Govoni M., Padovan M., Rubini M., Melchiorri L., et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008, 71:520-529.
27. Rizzo R., Hviid T.V., Stignani M., Balboni A., Grappa M.T., Melchiorri L., et al. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005, 57:172-181.
28. Twito T., Joseph J., Mociornita A., Rao V., Ross H., Delgado D.H. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2011, 30:778-782.
29. Rebmann V., LeMaoult J., Rouas-Freiss N., Carosella E.D., Grosse-Wilde H. Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007, 69(Suppl. 1):143-149.
30. Alegre E., Diaz-Lagares A., Lemaoult J., Lopez-Moratalla N., Carosella E.D., Gonzalez A. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum Immunol 2007, 68:661-667.
31. Sedlmayr P., Morales P., Trummer S., Wascher K., Azzola D., Blaschitz A. Absence of HLA-G expression in macrophages of human decidua. Am J Reprod Immunol 2002, 48:96-102.
32. Rasmussen M., Dahl M., Buus S., Djurisic S., Ohlsson J., Hviid T.V. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein. Tissue Antigens 2014.
33. Puppo F., Costa M., Contini P., Brenci S., Cevasco E., Ghio M., et al. Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy. Transpl Proc 1999, 31:1841-1843.
34. Steinborn A., Varkonyi T., Scharf A., Bahlmann F., Klee A., Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007, 57:277-286.
35. Yie S.M., Taylor R.N., Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005, 193:204-208.
36. Hackmon R., Hallak M., Krup M., Weitzman D., Sheiner E., Kaplan B., et al. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004, 19:404-409.
37. Rizzo R., Andersen A.S., Lassen M.R., Sorensen H.C., Bergholt T., Larsen M.H., et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2009, 62:320-338.
38. Hviid T.V. HLA-G genotype is associated with fetoplacental growth. Hum Immunol 2004, 65:586-593.
39. Hylenius S., Andersen A.M., Melbye M., Hviid T.V. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004, 10:237-246.
40. O'Brien M., McCarthy T., Jenkins D., Paul P., Dausset J., Carosella E.D., et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001, 58:1943-1949.
41. Hackmon R., Koifman A., Hyodo H., Glickman H., Sheiner E., Geraghty D.E. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 2007, 197(255):e1-e5.
42. Blaschitz A., Juch H., Volz A., Hutter H., Daxboeck C., Desoye G., et al. The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms. Mol Hum Reprod 2005, 11:699-710.
43. Dahl M, Klitkou L, Christiansen OB, Djurisic S, Piosik ZM, Skovbo P, Møller AM, Steffensen R, Hviid TV. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G. Hum Immunol 2015.